Edition:
United Kingdom

JXTG Holdings Inc (5020.T)

5020.T on Tokyo Stock Exchange

508JPY
7:00am BST
Change (% chg)

¥-22 (-4.12%)
Prev Close
¥529
Open
¥518
Day's High
¥518
Day's Low
¥506
Volume
25,113,900
Avg. Vol
18,611,315
52-wk High
¥901
52-wk Low
¥496

About

JXTG Holdings, Inc. is a holding company mainly engaged in energy business, metal business, petroleum and natural gas development business and other business. The Energy segment is engaged in the processing, manufacture and sale of petroleum products and petrochemical products, the storage and transportation of crude and refined... (more)

Overall

Beta: 0.64
Market Cap(Mil.): ¥1,954,028.00
Shares Outstanding(Mil.): 3,426.92
Dividend: 9.00
Yield (%): 2.81

Financials

  5020.T Industry Sector
P/E (TTM): 10.31 22.04 16.03
EPS (TTM): 55.30 -- --
ROI: 3.52 7.59 11.06
ROE: 7.85 10.19 14.14

Jera, JXTG sign EPC contract with Toshiba units for Goi power plant

TOKYO, June 28 Japan's Jera Co Inc and JXTG Nippon Oil & Energy Corp said on Friday they had signed a contract with two units of Toshiba Corp for construction of 2.34 gigawatt (GW) power generation facilities at the Goi thermal power station in eastern Japan.

28 Jun 2019

UPDATE 1-JXTG says gets supplies from Saudi, others to replace Iranian oil

* President says no truth to report on sale of Caserones mine

13 May 2019

UPDATE 1-Japan's TEPCO to enter hydrogen fuel business with JXTG

TOKYO, March 22 Japan's Tokyo Electric Power Company Holdings (TEPCO) and JXTG Holdings said on Friday they would build one of the world's biggest hydrogen stations in Tokyo by mid-2020, marking the entry of TEPCO to hydrogen fuel business.

22 Mar 2019

Japan's Fujifilm buys biologics unit from Biogen to boost healthcare business

TOKYO Japan's Fujifilm Holdings Corp will buy a drugmaking business from U.S.-based Biogen Inc for about $890 million (674.8 million pounds) to try to bolster its healthcare business as growth at its legacy photocopy operations stagnates.

12 Mar 2019

Japan's Fujifilm buys biologics unit from Biogen to boost healthcare business

TOKYO Japan's Fujifilm Holdings Corp will buy a drugmaking business from U.S.-based Biogen Inc for about $890 million to try to bolster its healthcare business as growth at its legacy photocopy operations stagnates.

12 Mar 2019

UPDATE 2-Japan's Fujifilm buys biologics unit from Biogen to boost healthcare business

* Fujifilm expects 100 bln yen revenue from CDMO business by 2021 (Adds details and background)

12 Mar 2019

Fujifilm says to buy Biogen's subsidiary for around $890 mln

TOKYO, March 12 Fujifilm Holdings Corp said on Tuesday it is buying a subsidiary of Biogen Inc , Biogen Denmark Manufacturing ApS, for around $890 million to bolster its healthcare business.

12 Mar 2019

Earnings vs. Estimates